SCSolmaz Chamanara

Solmaz Chamanara

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Solmaz Chamanara has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Generational Placental Dysfunction in a Family with LHON Mitochondrial Disease

    by Solmaz Chamanara, Lekha Chilakamarri, Sophia M. Adelson, Grant S. Wells, Matthew Neu, Tia Moscarello, Sneha Goenka, John E. Gorzynski, Megan Grove, Euan A. Ashley, et al.

    Objectives: Leber hereditary optic neuropathy (LHON) is the most prevalent primary mitochondrial disease caused by disease-causing variants in the mitochondrial DNA. While affected individuals generally present with visual impairment, some individuals develop LHON Plus, a multisystem phenotype with other neurological and systemic manifestations. This report describes a family with MT-ND4-related LHON with an atypical presentation of placental dysfunction in affected females, all experiencing fetal or neonatal demise, suggesting a potential association between pathogenic variants in MT-ND4 and adverse pregnancy outcomes. ,Design: Case report.,Subject: A 16-year-old male with acute onset of painless, binocular vision loss was admitted for expedited subspeciality evaluation. Maternal family history was notable for several female relatives with pre-eclampsia; hemolysis, elevated liver enzymes, low platelets (HELLP syndrome), late-gestation pregnancy loss, and/or neonatal demise. ,Interventions: Comprehensive ophthalmologic, systemic, and neurological evaluations, neuroimaging, and ultra-rapid genome sequencing (urGS) including mtDNA were performed. ,Results: A maternally-inherited pathogenic homoplasmic MT-ND4 variant (m.11778G>A) was detected in the male proband and several of his maternal relatives.,Conclusions: The reproductive phenotypes of the affected females in this family with MT-ND4-related LHON support expanding the clinical spectrum of "LHON plus" to include placental dysfunction. The segregation of the familial pathogenic variant in MT-ND4 in affected females with adverse pregnancy outcomes supports the notion of mitochondrial dysfunction contributing to placental dysfunction and poor maternal and perinatal outcomes. This family highlights the importance of acquiring a detailed family and reproductive history in individuals with LHON, or other mitochondrial disease, as high-risk pregnancy monitoring may be warranted for female patients and affected female maternal relatives.,Keywords:,Leber hereditary optic neuropathy (LHON), MT-ND4, m.11778G>A, Mitochondrial DNA, Placental dysfunction, Adverse pregnancy outcomes.

  • Open Access

    In Vitro Fertilization is Essential Healthcare for Patients With Rheumatic Disease

    by Amanda Moyer, Catherine A. Sims, Rosalind Ramsey‐Goldman, Solmaz Chamanara, Cuoghi Edens

    Infertility presents a profound physical, emotional, and financial burden, particularly for rheumatology patients who often face substantial barriers to family building. The 2024 Alabama Supreme Court ruling in LePage v. Center for Reproductive Medicine equating embryo destruction with wrongful death introduced new legal uncertainties, sparking concerns about access to in vitro fertilization (IVF) and reproductive health services across the United States. Although Alabama's subsequent legislative action granted temporary protections for fertility providers, the broader implications of embryo personhood laws remain unresolved. For patients with rheumatic diseases, timely access to assisted reproductive technology (ART) is essential. However, barriers such as limited ART awareness, concerns about safety and success, social and religious stigma, and financial and legal restrictions disproportionately impact this population. The consequences of restrictive policies extend beyond females, affecting men and same‐sex couples who rely on IVF to expand their families. Infertility is a recognized medical condition, and restricting ART access is medically and ethically indefensible. As physicians, researchers, and advocates, we must actively oppose legal decisions and policies that limit ART availability, including insurance restrictions, discriminatory practices, and embryo personhood legislation. Protecting and expanding ART access is critical—not only for rheumatology patients but for the one in eight couples and one in four physicians affected by infertility. Ensuring equitable, evidence‐based reproductive care is imperative to safeguarding the right to family building for all.

  • Open Access

    Predictors of Short‐Term and Long‐Term Latency After Preterm Premature Rupture of Membranes: A Retrospective Cohort Study

    by Shokoh Abotorabi, Maryam Rafiei, Solmaz Chamanara, Mark D. Griffiths, Zainab Alimoradi

    Background: Preterm premature rupture of the membranes (PPROM) is the spontaneous rupture of fetal membranes before the 37th gestational week. Despite the importance of the duration of the latency period (time duration between occurrence of PPROM and childbirth), the knowledge regarding its predictive factors is limited and inconsistent. Aim: The present study is aimed at identifying the predictive factors of short‐term and long‐term latency among PPROM cases. Methods: A retrospective cohort study was conducted using hospital‐based data from a single academic tertiary care hospital between January 2018 and December 2022. Demographic and clinical characteristics of 200 participants admitted due to PPROM were collected. Latency duration was categorized into three categories: less than 48 h; 48 h–7 days (considered as short‐term latency); and more than 7 days (considered as long‐term latency). In order to investigate the predictors of short‐term and long‐term latency among PPROM cases, univariable (using ꭓ 2 , Exact F statistic, and analysis of variance) and multivariable models (multivariable multinomial logistic regression model) were used. Results: The only significant predictor of latency duration between 48 h and 7 days, compared with latency duration of < 48 h, was lower gestational age at admission (4% decrease with each day increasing in gestational age at admission, p = 0.02). The significant predictors of latency duration of > 7 days compared with latency duration of < 48 h were lower gestational age at admission (8% decrease with each day increasing in gestational age at admission, p < 0.001), normal glucose tolerance status (7.95 times increased chance, p = 0.003), cervical dilation of p = 0.013), and pregnancy termination due to reaching 34 weeks of gestation (36.63 times increased chance, p < 0.001) compared with termination due to labor pain. These variables explained 42.3% of variance for latency duration. Conclusion: Obstetricians can expect longer latency period when PPROM cases are admitted at lower gestational age, having normal glucose tolerance status, and cervical dilation of <2 cm vs. ≥ 2 cm dilatation at admission.